Article
Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
The Journal of clinical endocrinology and metabolism - 1 Mar 2004
Sato Naoko, Katsumata Noriyuki, Kagami Masayo, Hasegawa Tomonobu, Hori Naoaki, Kawakita Setsuyo, Minowada Shigeru, Shimotsuka Aki, Shishiba Yoshimasa, Yokozawa Masato, Yasuda Toshiyuki, Nagasaki Keisuke, Hasegawa Daiichiro, Hasegawa Yukihiro, Tachibana Katsuhiko, Naiki Yasuhiro, Horikawa Reiko, Tanaka Toshiaki, Ogata Tsutomu
Abstract excerpt
We report on the clinical and molecular findings in 25 males and three females with Kallmann syndrome (KS) aged 10-53 yr. Ten males were from five families, and the remaining 15 males and three females were apparently sporadic cases. Molecular studies were performed for Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, also known as KAL2) by sequence analysis for all the coding exons, by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
